ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 112 filers reported holding ALBIREO PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,630,683 | +28.3% | 306,834 | +15.0% | 0.25% | +17.1% |
| Q3 2022 | $5,168,000 | +13.7% | 266,917 | +16.6% | 0.22% | +25.6% |
| Q2 2022 | $4,544,000 | -42.9% | 228,821 | -14.2% | 0.17% | -29.5% |
| Q1 2022 | $7,957,000 | +8.2% | 266,744 | -15.5% | 0.24% | +19.0% |
| Q4 2021 | $7,352,000 | -4.0% | 315,662 | +28.6% | 0.20% | -5.1% |
| Q3 2021 | $7,656,000 | +5.7% | 245,381 | +19.2% | 0.22% | +28.6% |
| Q2 2021 | $7,243,000 | +225.5% | 205,892 | +226.2% | 0.17% | +236.0% |
| Q1 2021 | $2,225,000 | – | 63,121 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |